ArticleCancer medicine2014

A molecular targeting against nuclear factor-κB, as a chemotherapeutic approach for human malignant mesothelioma.

Sho Nishikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.